78.59
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTVA Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$77.37
Aprire:
$77.38
Volume 24 ore:
13.36M
Relative Volume:
3.38
Capitalizzazione di mercato:
$52.56B
Reddito:
$17.89B
Utile/perdita netta:
$1.26B
Rapporto P/E:
46.15
EPS:
1.7029
Flusso di cassa netto:
$2.05B
1 W Prestazione:
+4.98%
1M Prestazione:
-3.07%
6M Prestazione:
+17.37%
1 anno Prestazione:
+6.03%
Corteva Inc Stock (CTVA) Company Profile
Nome
Corteva Inc
Settore
Industria
Telefono
(833) 267-8382
Indirizzo
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Compare CTVA vs NTR, CF, MOS, ICL
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CTVA
Corteva Inc
|
78.59 | 52.56B | 17.89B | 1.26B | 2.05B | 1.7029 |
|
NTR
Nutrien Ltd
|
62.86 | 30.17B | 27.83B | 2.42B | 2.21B | 4.9113 |
|
CF
Cf Industries Holdings Inc
|
102.93 | 15.81B | 7.41B | 2.12B | 1.62B | 11.13 |
|
MOS
Mosaic Company
|
22.90 | 7.28B | 12.05B | 575.40M | -534.60M | 1.6871 |
|
ICL
Icl Group Ltd
|
5.14 | 6.63B | 7.41B | 314.00M | 220.88M | 0.202 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-09 | Downgrade | UBS | Buy → Neutral |
| 2026-02-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-10-03 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-10-02 | Downgrade | Citigroup | Buy → Neutral |
| 2025-10-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-08-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-03-31 | Aggiornamento | Argus | Hold → Buy |
| 2025-03-13 | Iniziato | Goldman | Buy |
| 2024-10-23 | Iniziato | Citigroup | Buy |
| 2024-10-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-08-07 | Downgrade | Argus | Buy → Hold |
| 2024-04-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-03-01 | Iniziato | Wolfe Research | Outperform |
| 2024-02-12 | Aggiornamento | Loop Capital | Hold → Buy |
| 2024-02-02 | Aggiornamento | Exane BNP Paribas | Underperform → Neutral |
| 2023-11-27 | Downgrade | Berenberg | Buy → Hold |
| 2023-11-14 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-10-20 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-09-05 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-25 | Downgrade | Redburn | Buy → Neutral |
| 2023-06-28 | Iniziato | Canaccord Genuity | Buy |
| 2023-05-22 | Aggiornamento | Vertical Research | Hold → Buy |
| 2023-04-06 | Iniziato | Oppenheimer | Perform |
| 2023-01-19 | Iniziato | Wells Fargo | Overweight |
| 2023-01-11 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Downgrade | UBS | Buy → Neutral |
| 2022-11-15 | Downgrade | Loop Capital | Buy → Hold |
| 2022-08-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-08-08 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2022-07-14 | Iniziato | Credit Suisse | Outperform |
| 2022-06-01 | Iniziato | Barclays | Overweight |
| 2022-05-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-14 | Aggiornamento | Loop Capital | Hold → Buy |
| 2022-04-14 | Downgrade | Vertical Research | Buy → Hold |
| 2022-01-31 | Aggiornamento | Redburn | Neutral → Buy |
| 2021-10-18 | Downgrade | Loop Capital | Buy → Hold |
| 2021-10-13 | Iniziato | Mizuho | Buy |
| 2021-10-08 | Iniziato | ROTH Capital | Buy |
| 2021-09-01 | Iniziato | Berenberg | Buy |
| 2021-08-09 | Aggiornamento | Monness Crespi & Hardt | Sell → Neutral |
| 2021-05-10 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-04-19 | Aggiornamento | Loop Capital | Hold → Buy |
| 2021-02-05 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-02-05 | Reiterato | Monness Crespi & Hardt | Sell |
| 2020-12-18 | Downgrade | Susquehanna | Positive → Neutral |
| 2020-12-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-10 | Aggiornamento | Argus | Hold → Buy |
| 2020-10-19 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-10-19 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
| 2020-08-11 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-08-10 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-07-13 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2020-06-26 | Iniziato | Cleveland Research | Neutral |
| 2020-06-16 | Aggiornamento | Vertical Research | Hold → Buy |
| 2020-06-08 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
| 2020-05-11 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-04-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-04-17 | Aggiornamento | Loop Capital | Sell → Hold |
| 2020-04-01 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-31 | Aggiornamento | Susquehanna | Neutral → Positive |
| 2020-03-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-03-19 | Aggiornamento | Edward Jones | Hold → Buy |
| 2020-03-13 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-03-10 | Aggiornamento | Monness Crespi & Hardt | Sell → Neutral |
Mostra tutto
Corteva Inc Borsa (CTVA) Ultime notizie
Will FMC's (FMC) Rimisoxafen Deal With Corteva Reshape Its Cash Flow Repair Narrative? - simplywall.st
Why Corteva’s Lumialza seed treatment is drawing fresh attention from corn growers - AD HOC NEWS
US' FMC, Corteva partner to expand rimisoxafen weed control - Fibre2Fashion
How MustGrow Biologics Benefits from Agrochemical Realignment with Patented Bioactive Technology – Pressure on Bayer and Corteva - news.financial
Corteva Inc. stock outperforms competitors on strong trading day - MarketWatch
FMC and Corteva Partner to Expand Access to Rimisoxafen Technology - TradingView
What Corteva (CTVA)'s Rimisoxafen Deal With FMC Means For Shareholders - simplywall.st
Corteva Inc (CTVA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Corteva Inc (CTVA) Institutional Confidence - TradingKey
Corteva Inc (CTVA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Corteva stock ticks up to $77.45 as CortevaUS promotes photo contest for branded T-shirts - Traders Union
Corteva Inc (CTVA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Corteva Inc (CTVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CTVA: EU gene editing approval and tech advances drive growth, efficiency, and new crop opportunities - TradingView
Corteva Inc (CTVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
FMC Corp. (FMC) Partners with Corteva to Enhance Herbicide Techn - GuruFocus
FMC, Corteva announce co-exclusive rimisoxafen supply and license pact - TipRanks
FMC and Corteva partner on herbicide technology distribution By Investing.com - Investing.com South Africa
Fmc Corporation And Corteva Expand Access To Breakthrough Rimisoxafen Herbicide Technology - TradingView
FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology - PR Newswire
FMC & Corteva Unite: A New Front in the War on Herbicide-Resistant Weeds - BriefGlance
Corteva agrees to $85 million settlement - The Fence Post
Communities for a Better Environment v. Corteva Inc. et al. - NRDC
Entropy Technologies LP Has $2.28 Million Position in Corteva, Inc. $CTVA - MarketBeat
Corteva Inc (CTVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cortea raises €12M to help audit firms adopt AI without compromising audit quality - GlobeNewswire Inc.
Corteva Says No To FTC Trial Date In Pesticides Case - Law360
Can Higher Avocado Pricing Sustain Mission Produce's Growth? - TradingView
Corteva Inc Stock (US22052L1044): Analyst targets and valuation keep the shares in focus - AD HOC NEWS
Corteva (CTVA) Stock Valuation As Industry Commentary Highlights Growth Efforts And Ongoing Headwinds - Yahoo Finance
The Technical Signals Behind (CTVA) That Institutions Follow - Stock Traders Daily
Adams Natural Resources Fund Inc. Reduces Position in Corteva, Inc. $CTVA - MarketBeat
Corteva, Inc. Files Amended 8-K/A with SEC Detailing Company Information and Addresses - Minichart
Corteva (CTVA) Faces Increased Restructuring Costs and Legal Set - GuruFocus
Corteva (CTVA): New Buy Recommendation for This Basic Materials Giant - The Globe and Mail
Corteva (CTVA) Enhances Efficiency with Multi-Year Restructuring Plan - GuruFocus
Corteva flags higher restructuring charges, plans Spain site exit - Reuters
Corteva says setting trial date in US FTC case now would be 'premature' - MLex
Corteva sees higher restructuring charges, plans to cease production at Spanish site (CTVA:NYSE) - Seeking Alpha
Corteva Management Recently Committed To Next Phase Of Plan To Include Intended Cessation Of Co's Production Activities At Site In Asturias, Spain - TradingView
Corteva Is Maintained at Overweight by Barclays - Moomoo
Corteva raises restructuring charges, to shut Spain plant in cost-cut push - marketscreener.com
Corteva (CTVA) lifts crop protection restructuring charges and advances plant exits - Stock Titan
Corteva Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Corteva’s Innovation Pipeline Faces A Bigger Growth Test - Kalkine Media
Zacks Industry Outlook Highlights Corteva, Archer Daniels Midland, The Scotts, Miracle-Gro, Adecoagro and Mission Produce - Zacks Investment Research
Is Corteva stock underperforming the Dow? - MSN
Corteva Strikes $85M Deal In Farmer Pesticide Antitrust MDL - Law360
Corteva to pay $85 million to settle US farmers' lawsuit over pesticide prices - Reuters
CTVA Maintained by Barclays -- Price Target Raised to $91.00 - GuruFocus
More Than 100K Farmers to Share in $85M Corteva Settlement in Crop Loyalty Case - DTN Progressive Farmer
Corteva Inc Azioni (CTVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):